Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-031757
Filing Date
2018-05-09
Accepted
2018-05-09 16:53:10
Documents
31
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a18-13239_110q.htm 10-Q 151142
2 EX-3.1 a18-13239_1ex3d1.htm EX-3.1 15604
3 EX-3.2 a18-13239_1ex3d2.htm EX-3.2 183608
4 EX-31.1 a18-13239_1ex31d1.htm EX-31.1 10606
5 EX-31.2 a18-13239_1ex31d2.htm EX-31.2 10632
6 EX-32.1 a18-13239_1ex32d1.htm EX-32.1 5080
7 EX-32.2 a18-13239_1ex32d2.htm EX-32.2 5111
  Complete submission text file 0001104659-18-031757.txt   699892

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT nauhi-20180331.xml EX-101.INS 28824
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nauhi-20180331.xsd EX-101.SCH 10489
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nauhi-20180331_cal.xml EX-101.CAL 2572
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nauhi-20180331_def.xml EX-101.DEF 13168
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT nauhi-20180331_lab.xml EX-101.LAB 50283
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nauhi-20180331_pre.xml EX-101.PRE 36180
Mailing Address 4505 EMPEROR BLVD. SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BLVD. SUITE 200 DURHAM NC 27703 9198591302
Nautilus Holdco, Inc. (Filer) CIK: 0001732004 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-223255 | Film No.: 18819125
SIC: 2834 Pharmaceutical Preparations